Mostrando 10 resultados de: 13
Filtros aplicados
Publisher
Biochimica et Biophysica Acta - Molecular Basis of Disease(2)
Experimental Gerontology(2)
Expert Opinion on Investigational Drugs(1)
Expert Review of Neurotherapeutics(1)
International Journal of Biochemistry and Cell Biology(1)
Área temáticas
Enfermedades(13)
Fisiología humana(8)
Farmacología y terapéutica(4)
Problemas sociales y servicios a grupos(3)
Ginecología, obstetricia, pediatría, geriatría(1)
Origen
scopus(13)
Current Research Therapeutic Strategies for Alzheimer's Disease Treatment
ReviewAbstract: Alzheimer's disease (AD) currently presents one of the biggest healthcare issues in the developed coPalabras claves:Autores:Abad S., Antoni Camins, Auladell C., Ettcheto M., Folch J., García M.L., Olloquequi J., Petrov D., Sanchez-Lopez E., Zárate C.B.Fuentes:scopusAdipokine pathways are altered in hippocampus of an experimental mouse model of Alzheimer’s disease
ArticleAbstract: A growing body of evidence suggests that β-amyloid peptides (Aβ) are unlikely to be the only factorPalabras claves:ALZHÉIMER, APP/PS1, hippocampus, leptin, prolactinAutores:Abad S., Antoni Camins, Artiach G., Folch J., Pallás M., Pedros I., Petrov D., Ramon-Duaso C., Sureda F.X., Zárate C.B.Fuentes:scopusEvaluation of hypoxia inducible factor expression in inflammatory and neurodegenerative brain models
ArticleAbstract: The neuroinflammatory process is thought to contribute to the progression of neurological disordersPalabras claves:Alzheimer's, apoptosis, APP/PS1, c-Jun, HIF-1αAutores:Antoni Camins, Auladell C., Brox S., de la Torre A.V., De Lemos M.L., Folch J., Lazarowski A., Pallás M., Petrov D., Zárate C.B.Fuentes:scopusEvaluation of neuropathological effects of a high-fat diet in a presymptomatic Alzheimer's disease stage in APP/PS1 mice
ArticleAbstract: Alzheimer's disease (AD) is currently an incurable aging-related neurodegenerative disorder. RecentPalabras claves:Alzheimer's disease, APPswe/PS1dE9, hippocampus, insulin receptor, Mitochondria, TauAutores:Alva N., Antoni Camins, Auladell C., Carbonell T., Ettcheto M., Folch J., Pallás M., Pedros I., Petrov D., Zárate C.B.Fuentes:scopusEvaluation of the Role of JNK1 in the Hippocampus in an Experimental Model of Familial Alzheimer’s Disease
ArticleAbstract: c-Jun N-terminal kinases (JNKs), which belong to a mitogen-activated protein kinase (MAPK) family, aPalabras claves:Alzheimer’s disease, amyloid, Amyloid precursor protein, APPswe/PS1dE9, BACE1, JNK1, PGC-1α, Transgenic mouse models, β-secretase, βAAutores:Abad S., Antoni Camins, Auladell C., Ettcheto M., Folch J., Luque M., Pallás M., Pedros I., Petrov D., Verdaguer E.Fuentes:scopusEarly alterations in energy metabolism in the hippocampus of APPswe/PS1dE9 mouse model of Alzheimer's disease
ArticleAbstract: The present study had focused on the behavioral phenotype and gene expression profile of molecules rPalabras claves:Alzheimer's disease, APPswe/PS1dE9, hippocampus, insulin receptor, Mitochondria, TauAutores:Allgaier M., Antoni Camins, Auladell C., Barroso E., Casadesús G., Folch J., Pallás M., Pedros I., Petrov D., Sureda F.X., Vázquez-Carrera M., Zárate C.B.Fuentes:scopusHigh-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents
ArticleAbstract: Global obesity is a pandemic status, estimated to affect over 2 billion people, that has resulted inPalabras claves:Alzheimer disease, APPswe/PS1dE9, hippocampus, insulin receptor, Mitochondria, TauAutores:Antoni Camins, Artiach G., Barroso E., Carro E., Casadesús G., Ferrer I., Folch J., Pallás M., Pedros I., Petrov D., Sureda F.X., Vázquez-Carrera M., Zárate C.B.Fuentes:scopusHypercholesterolemia and neurodegeneration. Comparison of hippocampal phenotypes in LDLr knockout and APPswe/PS1dE9 mice
ArticleAbstract: Previous studies suggest that Alzheimer's disease (AD) neurobiology could not be explained solely byPalabras claves:Alzheimer's disease, APP/PS1, cholesterol, hippocampus, LDLR-/-, OXPHOSAutores:Alegret M., Antoni Camins, De Lemos M.L., Ettcheto M., Folch J., Laguna J.C., Pallás M., Pedros I., Petrov D.Fuentes:scopusMasitinib for the treatment of mild to moderate Alzheimer's disease
ReviewAbstract: Alzheimer's disease (AD) is a degenerative neurological disorder that is the most common cause of dePalabras claves:ALZHÉIMER, inflammation, masitinib, Neurodegeneration, TauAutores:Abad S., Antoni Camins, Auladell C., Ettcheto M., Folch J., Lazarowski A., Miguel Marin, Olloquequi J., Pedros I., Petrov D., Zárate C.B.Fuentes:scopusMavoglurant as a treatment for Parkinson's disease
ReviewAbstract: Introduction: A major unresolved issue in the Parkinson's disease (PD) treatment is the developmentPalabras claves:L-Dopa, Mavoglurant, Mlgu5, Parkinson's DiseaseAutores:Antoni Camins, Auladell C., Canudas A.M., De Lemos M.L., Folch J., Lazarowski A., Pallás M., Pedros I., Petrov D., Zárate C.B.Fuentes:scopus